New drug varieties of Hisilicon gradually enter the market
-
Last Update: 2014-09-30
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Statistics show that, as of yesterday, in the third quarter report of pre happy shares (excluding the listing of new shares in September), Hisense's accumulated net inflow of large single capital ranked eighth, reaching 153.8435 million yuan, with a cumulative increase of 6.44% over the same period, and the latest closing price of 22.14 yuan In terms of performance, according to the company's 2014 China Daily, the company expects a net profit of 373 million yuan to 480 million yuan from January to September 2014, a year-on-year increase of 5% to 35% (a year-on-year profit of 355 million yuan) Shanghai Securities expects the company to achieve earnings per share of 0.52 yuan and 0.66 yuan in 2014 and 2015 The median P / E ratios of Listed Companies in chemical industry in 2014 and 2015 were 37.14 times and 26.85 times respectively, and the dynamic P / E ratio of the company was the same as the industry average The growth of the company's old varieties is steady, and the gross profit rate has declined, but the new varieties gradually enter the market The company's sunflower growth plan is conducive to improving the company's academic promotion ability, the unique marketing mode is conducive to the rapid production of new varieties, improving the company's performance and gross profit level, and maintaining the company's rating of "prudent increase in holding in the next six months"
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
